News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

In the past, many women born with a heart condition were told they would not be able to birth children safely.